Medical device solenoid valves: what certification really requires

Why this happens

Engineers approaching a medical valve project usually prepare for the wrong examination. They expect the magnetics, the leakage and the cycle life to be scrutinised, and instead the questions are about paperwork that describes materials.

That is not bureaucracy for its own sake. In a regulated device, what has to be preserved after approval is the identity of the part. A magnetic curve can be re-verified on any sample in an afternoon; a material declaration cannot be reconstructed after the fact. So the audit concentrates on two things:

Material declaration at grade level. The wetted and patient-adjacent surfaces — the valve body, the seal, the plunger, the spring, any plating or coating — have to be declared with grade numbers you can defend, plus the applicable biocompatibility evidence for their contact category. The part of ISO 10993 that applies depends on whether contact is surface, external communicating, or implant, and on whether it is short, prolonged, or long term. Typically that means cytotoxicity, sensitisation and irritation testing for external communicating short-term contact, and more as the contact category escalates.

Traceability of the delivered item. A valve delivered in month eighteen has to be traceable to the specific material lots and the manufacturing records of the units that were validated. If your supplier buys resin by family name from an open market, that chain does not exist, and the gap becomes the device manufacturer’s problem.

The consequence for selection is simple: the material grade is a selection parameter, equal in weight to the force and the stroke. Choosing a bobbin resin for its deflection temperature and then discovering it is not the grade the customer validated is not a documentation problem — it is a redesign with a re-validation attached.

Check these in order

1. Establish the contact category before choosing any material. Where does the fluid go, what does it touch, and for how long? This single answer decides which materials are even candidates, and it should be settled before the first drawing.

2. Ask for the material declaration at grade level. A declaration that says “PPS” or “NBR” is not a specification. You want the manufacturer and the grade, and for the supplier to be able to repeat that statement in eighteen months.

3. Ask about lot-level material certificates, and test the answer. Specifically, ask how a valve shipped a year from now can be traced to the resin lot in the validated sample. A supplier that has never done this will answer vaguely, and that vagueness is exactly what an audit finds.

4. Decide the sterilisation method early, then verify material compatibility. Autoclave, ethylene oxide and gamma radiation each attack materials differently: autoclave is a heat and moisture exposure, gamma is an ionising exposure that can crosslink or embrittle polymers, ETO leaves residues that need aeration. A method chosen after tooling can force a material change and reopen validation.

5. Confirm the supplier sits within an auditable quality system. The device manufacturer has to be able to audit the supplier or rely on a certification that supports it. If the supplier cannot host an audit, the customer will usually design the part out.

6. Agree the change control route in writing. Material substitution, process change, and site change should arrive as a formal notice before shipment, not as a note in a delivery. This is the single most common source of a supplier being dropped late in a project.

What actually to change

Finding	What to change	Why not the other thing
Grade not declared, only family	Specify the manufacturer’s grade on the drawing	Performance claims do not reconstruct a material declaration
No lot-level traceability	Require material certificates per lot as a delivery condition	Retrofitting traceability after validation is not possible
Sterilisation method undecided	Fix it before tooling, then qualify materials to it	Some polymer and elastomer choices are reversible only by re-tooling
Supplier outside an auditable QMS	Change to one that can be audited	The device manufacturer carries the nonconformity, not the supplier
Change notification informal	Make change control a contractual condition	Verbal notification cannot be evidenced in an audit
Seal chosen purely on chemical resistance	Add sterilisation compatibility and leachables	Chemical resistance to the process fluid is only half the exposure

When it IS the harder problem

The fluid path material has to be declared but the customer will not commit to a sterilisation method. This is the case worth pushing back on. Every material decision downstream depends on it, and a design frozen without it will be reopened — usually at the worst moment, when tooling exists. It is more productive to freeze the sterilisation question than to design a valve that hopes to survive all three.

The customer wants a custom material combination with no prior use. A novel combination can be qualified, but the testing burden is real and the schedule has to carry it. The honest route is to prefer materials with existing device history for the surfaces that a reviewer will question, and spend the custom design effort where it earns something — the guide, the seat, the stroke.

A material change is needed for performance reasons after validation. This is where the value of a traceable supply chain shows up. If the change is identified early, it can be folded into the original submission as one package. If it is identified after approval, the same engineering work becomes a regulatory event. The lesson is to over-specify material grades at the beginning, because over-specifying costs nothing until you actually need to change one.